Walgreens Concludes Public Trading Era with Landmark Private Equity Acquisition

The curtain has fallen on Walgreens Boots Alliance’s tenure as a publicly traded entity. Private equity firm Sycamore Partners has finalized its $10 billion acquisition, transitioning the pharmaceutical retailer into private ownership. This watershed moment concludes nearly a century of public market presence for one of America’s most recognizable retail brands.

Under the terms of the completed deal, shareholders will receive $11.45 per share in cash, valuing the enterprise—including assumed debt—at approximately $23.7 billion. Investors will additionally retain contingent rights worth up to $3.00 per share, linked to future proceeds from the disposition of VillageMD investments. The immediate delisting of WBA stock from Nasdaq marks the definitive end of public trading for the company.

The acquisition price represents a... Read more...